CHAMPIONS ONCOLOGY, INC. Earnings Per Share (Diluted)
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Earnings Per Share (Diluted) of -$0.08 per share for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for the quarter ending 2026-04-30 was -$0.05.
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for the quarter ending 2026-01-31 was -$0.02, a 106.45% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for the quarter ending 2025-10-31 was $0.02, a 60.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for the quarter ending 2025-07-31 was -$0.03, a 133.33% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for fiscal 2026 was -$0.08, a 124.24% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for fiscal 2025 was $0.33.
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for fiscal 2024 was -$0.54.
- CHAMPIONS ONCOLOGY, INC. earnings per share, diluted for fiscal 2023 was -$0.39, a 1075.00% decline from fiscal 2022.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-07-27 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-07-27 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-07-27 | -$0.08 10-K · filed 2026-07-27 | ||||
| 2026-01-31 | -$0.02 10-Q · filed 2026-03-12 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.04 10-Q · filed 2026-03-12 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-07-27 | ||||
| 2025-10-31 | $0.02 10-Q · filed 2025-12-15 | -$0.01 10-Q · filed 2025-12-15 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-07-27 | $0.17 derived: net income ÷ weighted average shares · filed 2026-07-27 | ||||
| 2025-07-31 | -$0.03 10-Q · filed 2025-09-15 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-07-27 | $0.16 derived: net income ÷ weighted average shares · filed 2026-07-27 | $0.21 derived: net income ÷ weighted average shares · filed 2026-07-27 | ||||
| 2025-04-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-07-27 | $0.18 derived: net income ÷ weighted average shares · filed 2026-07-27 | $0.24 derived: net income ÷ weighted average shares · filed 2026-07-27 | $0.33 10-K · filed 2026-07-27 | ||||
| 2025-01-31 | $0.31 10-Q · filed 2026-03-12 | $0.37 derived: net income ÷ weighted average shares · filed 2026-03-12 | $0.46 10-Q · filed 2026-03-12 | $0.46 derived: net income ÷ weighted average shares · filed 2026-03-12 | ||||
| 2024-10-31 | $0.05 10-Q · filed 2025-12-15 | $0.15 10-Q · filed 2025-12-15 | $0.14 derived: net income ÷ weighted average shares · filed 2025-12-15 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-12-15 | ||||
| 2024-07-31 | $0.09 10-Q · filed 2025-09-15 | $0.09 derived: net income ÷ weighted average shares · filed 2025-09-15 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-09-15 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-09-15 | ||||
| 2024-04-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-07-23 | -$0.19 derived: net income ÷ weighted average shares · filed 2025-07-23 | -$0.35 derived: net income ÷ weighted average shares · filed 2025-07-23 | -$0.54 10-K · filed 2025-07-23 | ||||
| 2024-01-31 | -$0.19 10-Q · filed 2025-03-17 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$0.53 10-Q · filed 2025-03-17 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-03-17 | ||||
| 2023-10-31 | -$0.15 10-Q · filed 2024-12-16 | -$0.34 10-Q · filed 2024-12-16 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-12-16 | -$0.71 derived: net income ÷ weighted average shares · filed 2024-12-16 | ||||
| 2023-07-31 | -$0.19 10-Q · filed 2024-09-13 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-09-13 | -$0.56 derived: net income ÷ weighted average shares · filed 2024-09-13 | |||||
| 2023-04-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-07-19 | -$0.37 derived: net income ÷ weighted average shares · filed 2024-07-19 | -$0.39 10-K · filed 2024-07-19 | |||||
| 2023-01-31 | -$0.18 10-Q · filed 2024-03-15 | -$0.20 10-Q · filed 2024-03-15 | ||||||
| 2022-10-31 | $0.00 10-Q · filed 2023-12-13 | -$0.02 10-Q · filed 2023-12-13 | ||||||
| 2022-07-31 | -$0.02 10-Q · filed 2023-09-13 | |||||||
| 2022-04-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2023-07-24 | $0.03 derived: net income ÷ weighted average shares · filed 2023-07-24 | $0.05 derived: net income ÷ weighted average shares · filed 2023-07-24 | $0.04 10-K · filed 2023-07-24 | ||||
| 2022-01-31 | $0.05 10-Q · filed 2023-03-16 | $0.07 derived: net income ÷ weighted average shares · filed 2023-03-16 | $0.06 10-Q · filed 2023-03-16 | $0.02 derived: net income ÷ weighted average shares · filed 2023-03-16 | ||||
| 2021-10-31 | $0.02 10-Q · filed 2022-12-13 | $0.01 10-Q · filed 2022-12-13 | -$0.04 derived: net income ÷ weighted average shares · filed 2022-12-13 | $0.03 derived: net income ÷ weighted average shares · filed 2022-12-13 | ||||
| 2021-07-31 | -$0.01 10-Q · filed 2022-09-12 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-09-12 | $0.01 derived: net income ÷ weighted average shares · filed 2022-09-12 | $0.01 derived: net income ÷ weighted average shares · filed 2022-09-12 | ||||
| 2021-04-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-07-22 | $0.02 derived: net income ÷ weighted average shares · filed 2022-07-22 | $0.02 derived: net income ÷ weighted average shares · filed 2022-07-22 | $0.02 10-K · filed 2022-07-22 | ||||
| 2021-01-31 | $0.07 10-Q · filed 2022-03-15 | $0.05 10-Q · filed 2021-03-15 | $0.06 derived: net income ÷ weighted average shares · filed 2022-03-15 | $0.07 10-Q · filed 2022-03-15 | $0.06 10-Q · filed 2021-03-15 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-03-15 | ||
| 2020-10-31 | $0.00 10-Q · filed 2021-12-13 | $0.01 10-Q · filed 2021-12-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-12-13 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-12-13 | ||||
| 2020-07-31 | $0.01 10-Q · filed 2021-09-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2021-09-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2021-09-13 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-09-13 | ||||
| 2020-04-30 | -$0.31 derived: net income ÷ weighted average shares · filed 2021-07-26 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-07-26 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-07-26 | -$0.18 10-K · filed 2021-07-26 | -$0.17 10-K · filed 2020-07-28 | |||
| 2020-01-31 | $0.03 10-Q · filed 2021-03-15 | $0.05 derived: net income ÷ weighted average shares · filed 2021-03-15 | $0.01 10-Q · filed 2021-03-15 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-03-15 | ||||
| 2019-10-31 | $0.02 10-Q · filed 2020-12-14 | -$0.03 10-Q · filed 2020-12-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2020-12-14 | -$0.08 derived: net income ÷ weighted average shares · filed 2020-12-14 | ||||
| 2019-07-31 | -$0.06 10-Q · filed 2020-09-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2020-09-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2020-09-14 | -$0.08 derived: net income ÷ weighted average shares · filed 2020-09-14 | ||||
| 2019-04-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2020-07-28 | -$0.05 derived: net income ÷ weighted average shares · filed 2020-07-28 | -$0.03 derived: net income ÷ weighted average shares · filed 2020-07-28 | $0.01 10-K · filed 2020-07-28 | ||||
| 2019-01-31 | -$0.03 10-Q · filed 2020-03-16 | -$0.01 derived: net income ÷ weighted average shares · filed 2020-03-16 | $0.03 10-Q · filed 2020-03-16 | -$0.02 derived: net income ÷ weighted average shares · filed 2020-03-16 | ||||
| 2018-10-31 | $0.02 10-Q · filed 2019-12-16 | $0.06 10-Q · filed 2019-12-16 | $0.01 derived: net income ÷ weighted average shares · filed 2019-12-16 | $0.00 derived: net income ÷ weighted average shares · filed 2019-12-16 | ||||
| 2018-07-31 | $0.04 10-Q · filed 2019-09-16 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-09-16 | -$0.02 derived: net income ÷ weighted average shares · filed 2019-09-16 | -$0.03 derived: net income ÷ weighted average shares · filed 2019-09-16 | ||||
| 2018-04-30 | -$0.06 derived: net income ÷ weighted average shares · filed 2019-07-29 | -$0.06 derived: net income ÷ weighted average shares · filed 2019-07-29 | -$0.07 derived: net income ÷ weighted average shares · filed 2019-07-29 | -$0.13 10-K · filed 2019-07-29 | ||||
| 2018-01-31 | -$0.01 10-Q · filed 2019-03-18 | -$0.02 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$0.08 10-Q · filed 2019-03-18 | |||||
| 2017-10-31 | -$0.01 10-Q · filed 2018-12-17 | -$0.07 10-Q · filed 2018-12-17 | ||||||
| 2017-07-31 | -$0.06 10-Q · filed 2018-09-14 | |||||||
| 2016-04-30 | -$0.30 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$0.57 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$0.87 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$1.20 10-K · filed 2016-07-29 | ||||
| 2016-01-31 | -$0.28 10-Q · filed 2016-03-16 | -$0.57 derived: net income ÷ weighted average shares · filed 2016-03-16 | -$0.90 10-Q · filed 2016-03-16 | -$1.27 derived: net income ÷ weighted average shares · filed 2016-07-29 | ||||
| 2015-10-31 | -$0.29 10-Q · filed 2015-12-15 | -$0.63 10-Q · filed 2015-12-15 | -$0.99 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$1.52 derived: net income ÷ weighted average shares · filed 2016-07-29 | ||||
| 2015-07-31 | -$0.33 10-Q · filed 2015-09-11 | -$0.70 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$1.24 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$1.85 derived: net income ÷ weighted average shares · filed 2016-07-29 | ||||
| 2015-04-30 | -$0.37 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$0.92 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$1.55 derived: net income ÷ weighted average shares · filed 2016-07-29 | -$2.20 10-K · filed 2016-07-29 | -$0.18 10-K · filed 2015-07-29 | |||
| 2015-01-31 | -$0.61 10-Q · filed 2016-03-16 | -$0.05 10-Q · filed 2015-03-17 | -$1.27 derived: net income ÷ weighted average shares · filed 2016-03-16 | -$1.94 10-Q · filed 2016-03-16 | -$0.16 10-Q · filed 2015-03-17 | -$0.62 derived: net income ÷ weighted average shares · filed 2016-03-16 | ||
| 2014-10-31 | -$0.65 10-Q · filed 2015-12-15 | -$0.05 10-Q · filed 2014-12-15 | -$1.32 10-Q · filed 2015-12-15 | -$0.11 10-Q · filed 2014-12-15 | -$0.37 derived: net income ÷ weighted average shares · filed 2015-12-15 | -$0.31 derived: net income ÷ weighted average shares · filed 2015-12-15 | ||
| 2014-07-31 | -$0.64 10-Q · filed 2015-09-11 | -$0.16 derived: net income ÷ weighted average shares · filed 2015-09-11 | -$0.16 derived: net income ÷ weighted average shares · filed 2015-09-11 | -$0.19 derived: net income ÷ weighted average shares · filed 2015-09-11 | ||||
| 2014-04-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2015-07-29 | -$0.06 derived: net income ÷ weighted average shares · filed 2015-07-29 | -$0.09 derived: net income ÷ weighted average shares · filed 2015-07-29 | -$0.11 10-K · filed 2015-07-29 | ||||
| 2014-01-31 | -$0.02 10-Q · filed 2015-03-17 | -$0.06 derived: net income ÷ weighted average shares · filed 2015-03-17 | -$0.08 10-Q · filed 2015-03-17 | |||||
| 2013-10-31 | -$0.03 10-Q · filed 2014-12-15 | -$0.07 10-Q · filed 2014-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |